Home › Global Supply Chain

What we do

Supply that can be seen, planned and measured.

Our supply chain is managed under formal supplier qualification and material traceability procedures, from incoming raw material through to finished product release and delivery.

01

Capability

Six functions we hold rather than delegate.

Supplier qualification

Formal qualification of material suppliers, with traceability maintained from incoming raw material through to finished product release.

Demand planning

Forecasting connected back to the manufacturing site, so that production and replenishment planning respond to real consumption rather than to order history.

Safety stock & inventory

Explicit safety-stock policy by product, sized against demand variability and replenishment lead time rather than set as a single blanket rule.

Serialisation & traceability

Serialisation and master-data management appropriate to the destination market’s requirements.

Pharmacovigilance & recall

Adverse-event handling, complaint investigation and recall coordination, with defined responsibilities and tested procedures.

Continuity planning

Product lifecycle and continuity planning, including alternate-source development for inputs identified as single-source risks.

02

The scorecard

What we ask to be measured on.

A supply commitment that cannot be measured is a statement of intent. These are the measures we propose from the first shipment, reported to the customer rather than assessed internally.

Fill rateProportion of ordered units delivered complete
Stockout daysDays per product with no available stock
OTIFOn-time, in-full delivery performance
Lead timeManufacturer to destination market, measured end to end
Safety-stock coverDays of cover held against agreed policy
ExpiryValue and units lost to expiry in period
Complaint closureTime to close quality complaints and investigations
Recall readinessTested ability to trace and retrieve a batch
03

The staged model

Value before capital.

The largest early gain in an import-dependent system is not domestic production. It is a supply chain that can see its own demand. Each stage below has to earn the next one.

  1. Verify & select

    Credentials verified, legal and quality model defined, product-level demand data obtained, initial portfolio prioritised.

  2. Supply

    Controlled supply of authorised products, with safety stock, quality systems, pharmacovigilance and recall capability in place.

  3. Localise

    Warehousing, secondary packaging, labelling, serialisation and QC sampling established in-country.

  4. Manufacture

    Technology transfer for a validated portfolio, once demand, cost, quality and utilisation gates are satisfied.

Why this order. The common failure in pharmaceutical localisation is a plant built first and a market sought afterwards. Utilisation is the variable that decides whether a facility is an asset or a liability — so we prove demand and service performance before anyone commits capital to bricks.

Next step

Availability is usually the presenting problem.

Most conversations start there rather than with manufacturing ambition. That is generally the right order.